Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
NCT07457918· Phase 3· Verrica Pharmaceuticals Inc.· Source
Contact: Project Manager
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error